| Mei Ling Zheng, CRNP | |
|
178 W Street Rd, Feasterville Trevose, PA 19053-7817 | |
| (215) 710-6490 | |
| Not Available |
| Full Name | Mei Ling Zheng |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 178 W Street Rd, Feasterville Trevose, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124583570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | SP019181 (Pennsylvania) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | SP019181 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center | Langhorne, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trinity Health Mid-atlantic Medical Group | 7416861885 | 239 |
News Archive
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
Australian clinicians and researchers are coming together with leading experts from across the globe to drive innovation and access to break-through blood clot dissolving and clot removal treatment.
› Verified 6 days ago
| Entity Name | Trinity Health Mid-atlantic Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093771271 PECOS PAC ID: 7416861885 Enrollment ID: O20040326000613 |
News Archive
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
Australian clinicians and researchers are coming together with leading experts from across the globe to drive innovation and access to break-through blood clot dissolving and clot removal treatment.
› Verified 6 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
Australian clinicians and researchers are coming together with leading experts from across the globe to drive innovation and access to break-through blood clot dissolving and clot removal treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mei Ling Zheng, CRNP Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Mei Ling Zheng, CRNP 178 W Street Rd, Feasterville Trevose, PA 19053-7817 Ph: (215) 710-6490 |
News Archive
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
Australian clinicians and researchers are coming together with leading experts from across the globe to drive innovation and access to break-through blood clot dissolving and clot removal treatment.
› Verified 6 days ago